Article info
Original article
Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
- Correspondence to Dr Naoki Kanomata, Department of Pathology, Kawasaki Medical School, Matsushima 577, Kurashiki, Okayama 701-0192, Japan; kanomata_7{at}med.kawasaki-m.ac.jp
Citation
Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
Publication history
- Received January 4, 2013
- Revised March 5, 2013
- Accepted March 6, 2013
- First published March 29, 2013.
Online issue publication
June 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions